These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35180212)

  • 21. A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn
    Olgar Y; Turan B
    Can J Physiol Pharmacol; 2019 Jun; 97(6):528-535. PubMed ID: 30444646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapagliflozin Does Not Directly Affect Human α or β Cells.
    Dai C; Walker JT; Shostak A; Bouchi Y; Poffenberger G; Hart NJ; Jacobson DA; Calcutt MW; Bottino R; Greiner DL; Shultz LD; McGuinness OP; Dean ED; Powers AC
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32428240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes.
    Girard CA; Wunderlich FT; Shimomura K; Collins S; Kaizik S; Proks P; Abdulkader F; Clark A; Ball V; Zubcevic L; Bentley L; Clark R; Church C; Hugill A; Galvanovskis J; Cox R; Rorsman P; Brüning JC; Ashcroft FM
    J Clin Invest; 2009 Jan; 119(1):80-90. PubMed ID: 19065048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Inhibition of Inositol-Requiring Enzyme 1α RNase Activity Protects Pancreatic Beta Cell and Improves Diabetic Condition in Insulin Mutation-Induced Diabetes.
    Herlea-Pana O; Eeda V; Undi RB; Lim HY; Wang W
    Front Endocrinol (Lausanne); 2021; 12():749879. PubMed ID: 34675883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of membrane excitability in pancreatic β-cell glucotoxicity.
    Shyr ZA; Wang Z; York NW; Nichols CG; Remedi MS
    Sci Rep; 2019 May; 9(1):6952. PubMed ID: 31061431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.
    Hasnain SZ; Borg DJ; Harcourt BE; Tong H; Sheng YH; Ng CP; Das I; Wang R; Chen AC; Loudovaris T; Kay TW; Thomas HE; Whitehead JP; Forbes JM; Prins JB; McGuckin MA
    Nat Med; 2014 Dec; 20(12):1417-26. PubMed ID: 25362253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus.
    Remedi MS; Kurata HT; Scott A; Wunderlich FT; Rother E; Kleinridders A; Tong A; Brüning JC; Koster JC; Nichols CG
    Cell Metab; 2009 Feb; 9(2):140-51. PubMed ID: 19187772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
    Bonner C; Kerr-Conte J; Gmyr V; Queniat G; Moerman E; Thévenet J; Beaucamps C; Delalleau N; Popescu I; Malaisse WJ; Sener A; Deprez B; Abderrahmani A; Staels B; Pattou F
    Nat Med; 2015 May; 21(5):512-7. PubMed ID: 25894829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telmisartan protects against high glucose/high lipid-induced apoptosis and insulin secretion by reducing the oxidative and ER stress.
    Wang Y; Xue J; Li Y; Zhou X; Qiao S; Han D
    Cell Biochem Funct; 2019 Apr; 37(3):161-168. PubMed ID: 30907023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short-term Glucose Lowering Effects of Sodium-glucose Cotransporter 2 Inhibitors Confirmed by Flash Glucose Monitoring in Two Outpatients with Type 1 Diabetes].
    Habu M; Okada Y; Kurozumi A; Tanaka Y
    J UOEH; 2020; 42(4):359-364. PubMed ID: 33268615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
    Henry RR; Rosenstock J; Edelman S; Mudaliar S; Chalamandaris AG; Kasichayanula S; Bogle A; Iqbal N; List J; Griffen SC
    Diabetes Care; 2015 Mar; 38(3):412-9. PubMed ID: 25271207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-fat-diet-induced remission of diabetes in a subset of K
    Yan Z; Shyr ZA; Fortunato M; Welscher A; Alisio M; Martino M; Finck BN; Conway H; Remedi MS
    Diabetes Obes Metab; 2018 Nov; 20(11):2574-2584. PubMed ID: 29896801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing cx36 gap junction coupling compensates for overactive KATP channels to restore insulin secretion and prevent hyperglycemia in a mouse model of neonatal diabetes.
    Nguyen LM; Pozzoli M; Hraha TH; Benninger RK
    Diabetes; 2014 May; 63(5):1685-97. PubMed ID: 24458355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DPP4 inhibitor vildagliptin preserves β-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice.
    Shimizu S; Hosooka T; Matsuda T; Asahara S; Koyanagi-Kimura M; Kanno A; Bartolome A; Etoh H; Fuchita M; Teruyama K; Takahashi H; Inoue H; Mieda Y; Hashimoto N; Seino S; Kido Y
    J Mol Endocrinol; 2012 Oct; 49(2):125-35. PubMed ID: 22822047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells.
    Moon JS; Karunakaran U; Elumalai S; Lee IK; Lee HW; Kim YW; Won KC
    J Diabetes Complications; 2017 Jan; 31(1):21-30. PubMed ID: 27662780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.
    Wilding JP; Woo V; Rohwedder K; Sugg J; Parikh S;
    Diabetes Obes Metab; 2014 Feb; 16(2):124-36. PubMed ID: 23911013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoplasmic reticulum stress contributes to NMDA-induced pancreatic β-cell dysfunction in a CHOP-dependent manner.
    Huang XT; Liu W; Zhou Y; Sun M; Sun CC; Zhang CY; Tang SY
    Life Sci; 2019 Sep; 232():116612. PubMed ID: 31260687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive endoplasmic reticulum stress over time due to human insulin gene mutation contributes to pancreatic beta cell dysfunction.
    Amirruddin NS; Tan WX; Tan YS; Gardner DS; Bee YM; Verma CS; Hoon S; Lee KO; Teo AKK
    Diabetologia; 2021 Nov; 64(11):2534-2549. PubMed ID: 34448879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes.
    Balboa D; Saarimäki-Vire J; Borshagovski D; Survila M; Lindholm P; Galli E; Eurola S; Ustinov J; Grym H; Huopio H; Partanen J; Wartiovaara K; Otonkoski T
    Elife; 2018 Nov; 7():. PubMed ID: 30412052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
    Hamamoto S; Kanda Y; Shimoda M; Tatsumi F; Kohara K; Tawaramoto K; Hashiramoto M; Kaku K
    Diabetes Obes Metab; 2013 Feb; 15(2):153-63. PubMed ID: 22950702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.